How SBOM Supports The Secure Product Development Framework (SPDF)

The U.S. Food and Drug Administration (FDA) now enforces strict software transparency requirements through Section 524B of the FD&C Act for medical device manufacturers. As part of your Secure Product Development Framework, the FDA’s automated eSTAR system instantly verifies your software inventory upon submission. When you submit an SBOM report with static spreadsheets, missing data fields, or unmapped open-source code, it immediately causes a Refuse-to-Accept (RTA) hold. This means stopping the process of submission before a human reviewer can see it.

The key to avoiding these delays is combining the SBOM and SPDF. This blend of SBOM and SPDF acts as a tracking system rather than a last-minute paper chase for compliance. It reveals unwanted third-party code, eliminates false-alarm security alerts, and links software vulnerabilities to patient safety within the quality system.

In this article, you’ll find out how using SBOM for medical device SPDF can help you operationalize your SPDF, standardize machine-readable schemas, which are CycloneDX and SPDX, and automate build pipeline security.

Key Takeaways

SPDF ensures secure development, and SBOM enables software composition visibility.
FDA Section 524B requires a machine-readable SBOM compatible with SPDF.
Transitive dependencies and SOUP need to be considered for greater supply chain visibility.
SBOM mapping enhances SAST, SCA, threat modeling, and VEX.
Automated SBOMs through CI/CD ensure every software build stays current.
VEX focuses on exploiting vulnerabilities, not all of them.
Continuous monitoring helps manage vulnerabilities post-market effectively.
Combining SBOM with SPDF will result in a fully auditable software supply chain.
Source: https://qualysec.com/sbom-a ...